Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers.

[1]  I. Jialal,et al.  Antioxidants and atherosclerosis , 1992 .

[2]  M. Noakes,et al.  Dietary supplementation with orange and carrot juice in cigarette smokers lowers oxidation products in copper-oxidized low-density lipoproteins. , 1995, Journal of the American Dietetic Association.

[3]  I. Jialal,et al.  The Effect of α-Tocopherol Supplementation on LDL Oxidation: A Dose-Response Study , 1995 .

[4]  F. Cuccurullo,et al.  Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. , 1995, Atherosclerosis.

[5]  A. Khachadurian,et al.  Dietary supplementation with vitamins C and E inhibits in vitro oxidation of lipoproteins. , 1993, Journal of the American College of Nutrition.

[6]  S. Grundy,et al.  Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation. , 1993, Circulation.

[7]  P. Reaven,et al.  Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[8]  M. Freeman,et al.  Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. Anti- rather than prooxidant activity of vitamin C in the presence of transition metal ions. , 1993, The Journal of biological chemistry.

[9]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[10]  V. Herbert.  Everyone should be tested for iron disorders. , 1992, Journal of the American Dietetic Association.

[11]  T. Matsuo,et al.  Dietary ascorbic acid depresses plasma and low density lipoprotein lipid peroxidation in genetically scorbutic rats. , 1992, The Journal of nutrition.

[12]  Margaret S. Wu,et al.  Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine. , 1992, The Journal of clinical investigation.

[13]  J. Enstrom,et al.  Vitamin C Intake and Mortality among a Sample of the United States Population , 1992, Epidemiology.

[14]  F. Kok,et al.  Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[15]  L. Packer,et al.  Recycling of vitamin E in human low density lipoproteins. , 1992, Journal of lipid research.

[16]  B. Frei.  Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. , 1991, The American journal of clinical nutrition.

[17]  B. Ames,et al.  Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. , 1991, The Biochemical journal.

[18]  R. Hoffmann,et al.  Ascorbic acid requirements for smokers: analysis of a population survey. , 1991, The American journal of clinical nutrition.

[19]  H Tunstall-Pedoe,et al.  Antioxidant vitamin intakes assessed using a food-frequency questionnaire: correlation with biochemical status in smokers and non-smokers , 1991, British Journal of Nutrition.

[20]  S. Grundy,et al.  Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. , 1991, The Journal of clinical investigation.

[21]  P. Henriksson,et al.  The antioxidant butylated hydroxytoluene protects against atherosclerosis. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[22]  D. Harats,et al.  Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. , 1990, Atherosclerosis.

[23]  R. Ziegler,et al.  Alteration of plasma low density lipoprotein from smokers. , 1990, Atherosclerosis.

[24]  S. Grundy,et al.  Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. , 1990, Atherosclerosis.

[25]  H. Esterbauer,et al.  Continuous Monitoring of in Vztro Oxidation of Human Low Density Lipoprotein , 2009 .

[26]  A. Gown,et al.  Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. , 1989, The American journal of pathology.

[27]  D. Harats,et al.  Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. , 1989, Atherosclerosis.

[28]  J L Witztum,et al.  Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. , 1989, The Journal of clinical investigation.

[29]  B. Ames,et al.  Ascorbate is an outstanding antioxidant in human blood plasma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Haberland,et al.  Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. , 1988, Science.

[31]  S. Narumiya,et al.  Cholesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Bendich,et al.  Free radical tissue damage: protective role of antioxidant nutrients 1 , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  T. Carew,et al.  Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[34]  R. D. Situnayake,et al.  The Use of Different Lipids to Express Serum Tocopherol: Lipid Ratios for the Measurement of Vitamin E Status , 1986, Annals of clinical biochemistry.

[35]  C. Chow,et al.  Lower levels of vitamin C and carotenes in plasma of cigarette smokers. , 1986, Journal of the American College of Nutrition.

[36]  G. Lepage,et al.  Direct transesterification of all classes of lipids in a one-step reaction. , 1986, Journal of lipid research.

[37]  William A. Pryor,et al.  The Tar Radical ( s ) in Cigarette Smoke : ESR Studies , 2006 .

[38]  M. Brown,et al.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.

[39]  Gerrity Rg.  The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. , 1981 .

[40]  K. Imaida,et al.  Chronic toxicity of butylated hydroxytoluene in Wistar rats. , 1981, Food and cosmetics toxicology.

[41]  J. Packer,et al.  Direct observation of a free radical interaction between vitamin E and vitamin C , 1979, Nature.

[42]  S. Omaye,et al.  Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. , 1979, Methods in enzymology.

[43]  E. Ginter.  Cholesterol: Vitamin C Controls Its Transformation to Bile Acids , 1973, Science.

[44]  J. Cerven,et al.  Lowered cholesterol catabolism in guinea pigs with chronic ascorbic acid deficiency. , 1971, The American journal of clinical nutrition.

[45]  Willis Gc.  The reversibility of atherosclerosis. , 1957, Canadian Medical Association journal.

[46]  Nutrition Board,et al.  RECOMMENDED DIETARY ALLOWANCES. , 1964, Clinical pediatrics.

[47]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.